Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Boehringer Ingelheim
Citi
Moodys
Healthtrust
Cerilliant
Mallinckrodt
Farmers Insurance
QuintilesIMS

Generated: April 27, 2018

DrugPatentWatch Database Preview

PREVACID NAPRAPAC 500 (COPACKAGED) Drug Profile

« Back to Dashboard

Which patents cover Prevacid Naprapac 500 (copackaged), and what generic alternatives are available?

Prevacid Naprapac 500 (copackaged) is a drug marketed by Takeda Pharms Na and is included in one NDA.

The generic ingredient in PREVACID NAPRAPAC 500 (COPACKAGED) is lansoprazole; naproxen. There are fifty-six drug master file entries for this compound. Additional details are available on the lansoprazole; naproxen profile page.
Summary for PREVACID NAPRAPAC 500 (COPACKAGED)
Drug patent expirations by year for PREVACID NAPRAPAC 500 (COPACKAGED)

US Patents and Regulatory Information for PREVACID NAPRAPAC 500 (COPACKAGED)

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Takeda Pharms Na PREVACID NAPRAPAC 500 (COPACKAGED) lansoprazole; naproxen CAPSULE, DELAYED REL PELLETS, TABLET;ORAL 021507-004 Nov 14, 2003 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for PREVACID NAPRAPAC 500 (COPACKAGED)

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Takeda Pharms Na PREVACID NAPRAPAC 500 (COPACKAGED) lansoprazole; naproxen CAPSULE, DELAYED REL PELLETS, TABLET;ORAL 021507-004 Nov 14, 2003 ➤ Try a Free Trial ➤ Try a Free Trial
Takeda Pharms Na PREVACID NAPRAPAC 500 (COPACKAGED) lansoprazole; naproxen CAPSULE, DELAYED REL PELLETS, TABLET;ORAL 021507-004 Nov 14, 2003 ➤ Try a Free Trial ➤ Try a Free Trial
Takeda Pharms Na PREVACID NAPRAPAC 500 (COPACKAGED) lansoprazole; naproxen CAPSULE, DELAYED REL PELLETS, TABLET;ORAL 021507-004 Nov 14, 2003 ➤ Try a Free Trial ➤ Try a Free Trial
Takeda Pharms Na PREVACID NAPRAPAC 500 (COPACKAGED) lansoprazole; naproxen CAPSULE, DELAYED REL PELLETS, TABLET;ORAL 021507-004 Nov 14, 2003 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Medtronic
Teva
Covington
QuintilesIMS
Cantor Fitzgerald
Julphar
Dow
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.